Division of Amgen Inc.
Latest From Bergamo
Pfizer, Novartis and Abbott reportedly are battling to buy out family-owned Ache, Brazil’s leader in prescription drug sales.
Pfizer, Novartis and Abbott reportedly are battling to buy out family-owned Ache, Brazil’s leader in prescription drug sales. Plus deals involving AstraZeneca and AlphaCore, Pfizer and Bind Therapeutics and Merck and Ra Pharma.
Amgen is expected to announce a JV in Japan soon, the company said during a business strategy meeting last week. It expects China, Japan and other emerging markets to bring in roughly $1 billion more in revenue by 2015.
A mixed first half and second quarter for big pharmas in emerging markets, as companies did well in select countries, notably China, but faced economic downturns and generics elsewhere.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.